Here's how LINK.SPRINGER.COM makes money* and how much!

*Please read our disclaimer before using our estimates.
Loading...

LINK . SPRINGER . COM {}

  1. Analyzed Page
  2. Matching Content Categories
  3. CMS
  4. Monthly Traffic Estimate
  5. How Does Link.springer.com Make Money
  6. Keywords
  7. Topics
  8. Questions
  9. Schema
  10. External Links
  11. Analytics And Tracking
  12. Libraries

We are analyzing https://link.springer.com/article/10.1007/s13402-019-00430-6.

Title:
Importance of CD45RO+ tumor-infiltrating lymphocytes in post-operative survival of breast cancer patients | Cellular Oncology
Description:
Purpose In recent years, the prognostic/predictive significance of tumor infiltrating lymphocytes (TILs) has become a topic of interest. Here, we aimed to evaluate the prognostic significance of CD3+, CD8+, CD45RO+ and Foxp3+ TILs in breast cancer, as well as the relation of these markers to other clinicopathological features of this disease. Methods FFPE tumor samples from 94 females with invasive ductal carcinoma of the breast were retrospectively selected and immunohistochemically assessed for CD3, CD8, CD45RO and Foxp3 expression. Digital photos were acquired from the center (CT) and invasive margins (IM) of the tumors, after which positive cells were counted using ImageJ software. Results We found that greater infiltrations of target lymphocyte subpopulations were associated with TNM stage III, lymph node metastasis, high histological grade, ER negativity and HER2 positivity. The ratios of CD8+ cytotoxic T cells to CD3+, CD45RO+ and Foxp3+ TILs were found to be relatively higher in tumors exhibiting the aforementioned characteristics. In univariate survival analyses, CD8+ TILs in the IM and total CD45RO+ TILs were found to be significantly associated with overall survival (OS). Infiltration of CD45RO+ TILs in the CT and lymph node status were variables that significantly correlated with disease-free survival (DFS). Multiple Cox regression analyses revealed independent significant prognostic effects of total CD45RO+ TILs and lymph node status (HR of 3.24 and 3.19, respectively) in predicting OS. Infiltration of CD45RO+ TILs in the CT (HR 3.12) and lymph node status (HR 3.15) also exhibited significant prognostic effects on DFS. Conclusion From our data we conclude that CD45RO+ TILs serve as prognostic factors for predicting OS and DFS of breast cancer patients.
Website Age:
28 years and 1 months (reg. 1997-05-29).

Matching Content Categories {📚}

  • Education
  • Health & Fitness
  • Science

Content Management System {📝}

What CMS is link.springer.com built with?

Custom-built

No common CMS systems were detected on Link.springer.com, and no known web development framework was identified.

Traffic Estimate {📈}

What is the average monthly size of link.springer.com audience?

🌠 Phenomenal Traffic: 5M - 10M visitors per month


Based on our best estimate, this website will receive around 5,000,019 visitors per month in the current month.
However, some sources were not loaded, we suggest to reload the page to get complete results.

check SE Ranking
check Ahrefs
check Similarweb
check Ubersuggest
check Semrush

How Does Link.springer.com Make Money? {💸}

We're unsure if the website is profiting.

Some websites aren't about earning revenue; they're built to connect communities or raise awareness. There are numerous motivations behind creating websites. This might be one of them. Link.springer.com could be getting rich in stealth mode, or the way it's monetizing isn't detectable.

Keywords {🔍}

cancer, pubmed, article, breast, google, scholar, cas, prognostic, lymphocytes, cdro, tumorinfiltrating, cells, central, cell, oncol, shiraz, patients, tumor, tils, survival, lymph, memory, ghaderi, ahmadvand, faghih, significance, access, wang, clin, iran, research, pages, simin, carcinoma, node, res, university, medical, sciences, privacy, cookies, content, safaei, talei, lymphocyte, infiltration, cancers, berger, galon, colorectal,

Topics {✒️}

month download article/chapter her2-positive breast cancers pubmed  google scholar article  google scholar triple-negative breast cancers pd-1/ pd-l1 expression t-cell metagene predicts histopathologic-based prognostic factors tumor-infiltrating lymphocyte composition tumour-infiltrating cd8+ lymphocytes early-stage colorectal cancer tumor-infiltrating lymphocyte subtype cd45ro+ tumor-infiltrating lymphocytes cd8 + tumor-infiltrating lymphocytes tumor-infiltrating foxp3+ regulatory tnm stage iii related subjects cd8+ t-cell infiltration abdol-rasoul talei tumour-infiltrating lymphocytes privacy choices/manage cookies cancer research [grant univariate survival analyses cells predict outcome tumour-infiltrating memory full article pdf simin ahmadvand triple negative cancer treat breast cancer tumor infiltrating lymphocytes tumor-infiltrating lymphocytes operable breast cancer metastatic lymph nodes google scholar article ahmadvand tumour proliferative activity lymph node status lymph node count lymph node microenvironment female breast cancer breast cancer depends early breast cancer tumor-infiltrating cd45ro tumor-infiltrating cd4 renal cell carcinoma breast cancer patients driving tumor development estrogen receptor-negative primary systemic therapy inflammatory cell reaction

Questions {❓}

  • Saidijam, Emerging ways to treat breast cancer: Will promises be met?

Schema {🗺️}

WebPage:
      mainEntity:
         headline:Importance of CD45RO+ tumor-infiltrating lymphocytes in post-operative survival of breast cancer patients
         description:In recent years, the prognostic/predictive significance of tumor infiltrating lymphocytes (TILs) has become a topic of interest. Here, we aimed to evaluate the prognostic significance of CD3+, CD8+, CD45RO+ and Foxp3+ TILs in breast cancer, as well as the relation of these markers to other clinicopathological features of this disease. FFPE tumor samples from 94 females with invasive ductal carcinoma of the breast were retrospectively selected and immunohistochemically assessed for CD3, CD8, CD45RO and Foxp3 expression. Digital photos were acquired from the center (CT) and invasive margins (IM) of the tumors, after which positive cells were counted using ImageJ software. We found that greater infiltrations of target lymphocyte subpopulations were associated with TNM stage III, lymph node metastasis, high histological grade, ER negativity and HER2 positivity. The ratios of CD8+ cytotoxic T cells to CD3+, CD45RO+ and Foxp3+ TILs were found to be relatively higher in tumors exhibiting the aforementioned characteristics. In univariate survival analyses, CD8+ TILs in the IM and total CD45RO+ TILs were found to be significantly associated with overall survival (OS). Infiltration of CD45RO+ TILs in the CT and lymph node status were variables that significantly correlated with disease-free survival (DFS). Multiple Cox regression analyses revealed independent significant prognostic effects of total CD45RO+ TILs and lymph node status (HR of 3.24 and 3.19, respectively) in predicting OS. Infiltration of CD45RO+ TILs in the CT (HR 3.12) and lymph node status (HR 3.15) also exhibited significant prognostic effects on DFS. From our data we conclude that CD45RO+ TILs serve as prognostic factors for predicting OS and DFS of breast cancer patients.
         datePublished:2019-03-01T00:00:00Z
         dateModified:2019-03-01T00:00:00Z
         pageStart:343
         pageEnd:356
         sameAs:https://doi.org/10.1007/s13402-019-00430-6
         keywords:
            Breast cancer
            Tumor-infiltrating lymphocytes
            CD45RO+ memory T cell
            CD8+ cytotoxic T cell
            Prognostic marker
            Cancer Research
            Biomedicine
            general
            Pathology
            Oncology
         image:
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs13402-019-00430-6/MediaObjects/13402_2019_430_Fig1_HTML.png
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs13402-019-00430-6/MediaObjects/13402_2019_430_Fig2_HTML.png
         isPartOf:
            name:Cellular Oncology
            issn:
               2211-3436
               2211-3428
            volumeNumber:42
            type:
               Periodical
               PublicationVolume
         publisher:
            name:Springer Netherlands
            logo:
               url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
               type:ImageObject
            type:Organization
         author:
               name:Simin Ahmadvand
               affiliation:
                     name:Shiraz University of Medical Sciences
                     address:
                        name:Department of Immunology, School of Medicine, Shiraz University of Medical Sciences, Shiraz, Iran
                        type:PostalAddress
                     type:Organization
                     name:Shiraz University of Medical Sciences
                     address:
                        name:Shiraz Institute for Cancer Research, School of Medicine, Shiraz University of Medical Sciences, Shiraz, Iran
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Zahra Faghih
               affiliation:
                     name:Shiraz University of Medical Sciences
                     address:
                        name:Shiraz Institute for Cancer Research, School of Medicine, Shiraz University of Medical Sciences, Shiraz, Iran
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Mehdi Montazer
               affiliation:
                     name:Shiraz University of Medical Sciences
                     address:
                        name:Department of Pathology, School of Medicine, Shiraz University of Medical Sciences, Shiraz, Iran
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Akbar Safaei
               affiliation:
                     name:Shiraz University of Medical Sciences
                     address:
                        name:Department of Pathology, School of Medicine, Shiraz University of Medical Sciences, Shiraz, Iran
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Maral Mokhtari
               affiliation:
                     name:Shiraz University of Medical Sciences
                     address:
                        name:Department of Pathology, School of Medicine, Shiraz University of Medical Sciences, Shiraz, Iran
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Peyman Jafari
               affiliation:
                     name:Shiraz University of Medical Sciences
                     address:
                        name:Department of Biostatistics, Shiraz University of Medical Sciences, Shiraz, Iran
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Abdol-Rasoul Talei
               affiliation:
                     name:Shiraz University of Medical Sciences
                     address:
                        name:Breast Disease Research Center, School of Medicine, Shiraz University of Medical Sciences, Shiraz, Iran
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Sedigheh Tahmasebi
               affiliation:
                     name:Shiraz University of Medical Sciences
                     address:
                        name:Breast Disease Research Center, School of Medicine, Shiraz University of Medical Sciences, Shiraz, Iran
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Abbas Ghaderi
               url:http://orcid.org/0000-0003-0849-3375
               affiliation:
                     name:Shiraz University of Medical Sciences
                     address:
                        name:Department of Immunology, School of Medicine, Shiraz University of Medical Sciences, Shiraz, Iran
                        type:PostalAddress
                     type:Organization
                     name:Shiraz University of Medical Sciences
                     address:
                        name:Shiraz Institute for Cancer Research, School of Medicine, Shiraz University of Medical Sciences, Shiraz, Iran
                        type:PostalAddress
                     type:Organization
               email:[email protected]
               type:Person
         isAccessibleForFree:
         hasPart:
            isAccessibleForFree:
            cssSelector:.main-content
            type:WebPageElement
         type:ScholarlyArticle
      context:https://schema.org
ScholarlyArticle:
      headline:Importance of CD45RO+ tumor-infiltrating lymphocytes in post-operative survival of breast cancer patients
      description:In recent years, the prognostic/predictive significance of tumor infiltrating lymphocytes (TILs) has become a topic of interest. Here, we aimed to evaluate the prognostic significance of CD3+, CD8+, CD45RO+ and Foxp3+ TILs in breast cancer, as well as the relation of these markers to other clinicopathological features of this disease. FFPE tumor samples from 94 females with invasive ductal carcinoma of the breast were retrospectively selected and immunohistochemically assessed for CD3, CD8, CD45RO and Foxp3 expression. Digital photos were acquired from the center (CT) and invasive margins (IM) of the tumors, after which positive cells were counted using ImageJ software. We found that greater infiltrations of target lymphocyte subpopulations were associated with TNM stage III, lymph node metastasis, high histological grade, ER negativity and HER2 positivity. The ratios of CD8+ cytotoxic T cells to CD3+, CD45RO+ and Foxp3+ TILs were found to be relatively higher in tumors exhibiting the aforementioned characteristics. In univariate survival analyses, CD8+ TILs in the IM and total CD45RO+ TILs were found to be significantly associated with overall survival (OS). Infiltration of CD45RO+ TILs in the CT and lymph node status were variables that significantly correlated with disease-free survival (DFS). Multiple Cox regression analyses revealed independent significant prognostic effects of total CD45RO+ TILs and lymph node status (HR of 3.24 and 3.19, respectively) in predicting OS. Infiltration of CD45RO+ TILs in the CT (HR 3.12) and lymph node status (HR 3.15) also exhibited significant prognostic effects on DFS. From our data we conclude that CD45RO+ TILs serve as prognostic factors for predicting OS and DFS of breast cancer patients.
      datePublished:2019-03-01T00:00:00Z
      dateModified:2019-03-01T00:00:00Z
      pageStart:343
      pageEnd:356
      sameAs:https://doi.org/10.1007/s13402-019-00430-6
      keywords:
         Breast cancer
         Tumor-infiltrating lymphocytes
         CD45RO+ memory T cell
         CD8+ cytotoxic T cell
         Prognostic marker
         Cancer Research
         Biomedicine
         general
         Pathology
         Oncology
      image:
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs13402-019-00430-6/MediaObjects/13402_2019_430_Fig1_HTML.png
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs13402-019-00430-6/MediaObjects/13402_2019_430_Fig2_HTML.png
      isPartOf:
         name:Cellular Oncology
         issn:
            2211-3436
            2211-3428
         volumeNumber:42
         type:
            Periodical
            PublicationVolume
      publisher:
         name:Springer Netherlands
         logo:
            url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
            type:ImageObject
         type:Organization
      author:
            name:Simin Ahmadvand
            affiliation:
                  name:Shiraz University of Medical Sciences
                  address:
                     name:Department of Immunology, School of Medicine, Shiraz University of Medical Sciences, Shiraz, Iran
                     type:PostalAddress
                  type:Organization
                  name:Shiraz University of Medical Sciences
                  address:
                     name:Shiraz Institute for Cancer Research, School of Medicine, Shiraz University of Medical Sciences, Shiraz, Iran
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Zahra Faghih
            affiliation:
                  name:Shiraz University of Medical Sciences
                  address:
                     name:Shiraz Institute for Cancer Research, School of Medicine, Shiraz University of Medical Sciences, Shiraz, Iran
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Mehdi Montazer
            affiliation:
                  name:Shiraz University of Medical Sciences
                  address:
                     name:Department of Pathology, School of Medicine, Shiraz University of Medical Sciences, Shiraz, Iran
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Akbar Safaei
            affiliation:
                  name:Shiraz University of Medical Sciences
                  address:
                     name:Department of Pathology, School of Medicine, Shiraz University of Medical Sciences, Shiraz, Iran
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Maral Mokhtari
            affiliation:
                  name:Shiraz University of Medical Sciences
                  address:
                     name:Department of Pathology, School of Medicine, Shiraz University of Medical Sciences, Shiraz, Iran
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Peyman Jafari
            affiliation:
                  name:Shiraz University of Medical Sciences
                  address:
                     name:Department of Biostatistics, Shiraz University of Medical Sciences, Shiraz, Iran
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Abdol-Rasoul Talei
            affiliation:
                  name:Shiraz University of Medical Sciences
                  address:
                     name:Breast Disease Research Center, School of Medicine, Shiraz University of Medical Sciences, Shiraz, Iran
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Sedigheh Tahmasebi
            affiliation:
                  name:Shiraz University of Medical Sciences
                  address:
                     name:Breast Disease Research Center, School of Medicine, Shiraz University of Medical Sciences, Shiraz, Iran
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Abbas Ghaderi
            url:http://orcid.org/0000-0003-0849-3375
            affiliation:
                  name:Shiraz University of Medical Sciences
                  address:
                     name:Department of Immunology, School of Medicine, Shiraz University of Medical Sciences, Shiraz, Iran
                     type:PostalAddress
                  type:Organization
                  name:Shiraz University of Medical Sciences
                  address:
                     name:Shiraz Institute for Cancer Research, School of Medicine, Shiraz University of Medical Sciences, Shiraz, Iran
                     type:PostalAddress
                  type:Organization
            email:[email protected]
            type:Person
      isAccessibleForFree:
      hasPart:
         isAccessibleForFree:
         cssSelector:.main-content
         type:WebPageElement
["Periodical","PublicationVolume"]:
      name:Cellular Oncology
      issn:
         2211-3436
         2211-3428
      volumeNumber:42
Organization:
      name:Springer Netherlands
      logo:
         url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
         type:ImageObject
      name:Shiraz University of Medical Sciences
      address:
         name:Department of Immunology, School of Medicine, Shiraz University of Medical Sciences, Shiraz, Iran
         type:PostalAddress
      name:Shiraz University of Medical Sciences
      address:
         name:Shiraz Institute for Cancer Research, School of Medicine, Shiraz University of Medical Sciences, Shiraz, Iran
         type:PostalAddress
      name:Shiraz University of Medical Sciences
      address:
         name:Shiraz Institute for Cancer Research, School of Medicine, Shiraz University of Medical Sciences, Shiraz, Iran
         type:PostalAddress
      name:Shiraz University of Medical Sciences
      address:
         name:Department of Pathology, School of Medicine, Shiraz University of Medical Sciences, Shiraz, Iran
         type:PostalAddress
      name:Shiraz University of Medical Sciences
      address:
         name:Department of Pathology, School of Medicine, Shiraz University of Medical Sciences, Shiraz, Iran
         type:PostalAddress
      name:Shiraz University of Medical Sciences
      address:
         name:Department of Pathology, School of Medicine, Shiraz University of Medical Sciences, Shiraz, Iran
         type:PostalAddress
      name:Shiraz University of Medical Sciences
      address:
         name:Department of Biostatistics, Shiraz University of Medical Sciences, Shiraz, Iran
         type:PostalAddress
      name:Shiraz University of Medical Sciences
      address:
         name:Breast Disease Research Center, School of Medicine, Shiraz University of Medical Sciences, Shiraz, Iran
         type:PostalAddress
      name:Shiraz University of Medical Sciences
      address:
         name:Breast Disease Research Center, School of Medicine, Shiraz University of Medical Sciences, Shiraz, Iran
         type:PostalAddress
      name:Shiraz University of Medical Sciences
      address:
         name:Department of Immunology, School of Medicine, Shiraz University of Medical Sciences, Shiraz, Iran
         type:PostalAddress
      name:Shiraz University of Medical Sciences
      address:
         name:Shiraz Institute for Cancer Research, School of Medicine, Shiraz University of Medical Sciences, Shiraz, Iran
         type:PostalAddress
ImageObject:
      url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
Person:
      name:Simin Ahmadvand
      affiliation:
            name:Shiraz University of Medical Sciences
            address:
               name:Department of Immunology, School of Medicine, Shiraz University of Medical Sciences, Shiraz, Iran
               type:PostalAddress
            type:Organization
            name:Shiraz University of Medical Sciences
            address:
               name:Shiraz Institute for Cancer Research, School of Medicine, Shiraz University of Medical Sciences, Shiraz, Iran
               type:PostalAddress
            type:Organization
      name:Zahra Faghih
      affiliation:
            name:Shiraz University of Medical Sciences
            address:
               name:Shiraz Institute for Cancer Research, School of Medicine, Shiraz University of Medical Sciences, Shiraz, Iran
               type:PostalAddress
            type:Organization
      name:Mehdi Montazer
      affiliation:
            name:Shiraz University of Medical Sciences
            address:
               name:Department of Pathology, School of Medicine, Shiraz University of Medical Sciences, Shiraz, Iran
               type:PostalAddress
            type:Organization
      name:Akbar Safaei
      affiliation:
            name:Shiraz University of Medical Sciences
            address:
               name:Department of Pathology, School of Medicine, Shiraz University of Medical Sciences, Shiraz, Iran
               type:PostalAddress
            type:Organization
      name:Maral Mokhtari
      affiliation:
            name:Shiraz University of Medical Sciences
            address:
               name:Department of Pathology, School of Medicine, Shiraz University of Medical Sciences, Shiraz, Iran
               type:PostalAddress
            type:Organization
      name:Peyman Jafari
      affiliation:
            name:Shiraz University of Medical Sciences
            address:
               name:Department of Biostatistics, Shiraz University of Medical Sciences, Shiraz, Iran
               type:PostalAddress
            type:Organization
      name:Abdol-Rasoul Talei
      affiliation:
            name:Shiraz University of Medical Sciences
            address:
               name:Breast Disease Research Center, School of Medicine, Shiraz University of Medical Sciences, Shiraz, Iran
               type:PostalAddress
            type:Organization
      name:Sedigheh Tahmasebi
      affiliation:
            name:Shiraz University of Medical Sciences
            address:
               name:Breast Disease Research Center, School of Medicine, Shiraz University of Medical Sciences, Shiraz, Iran
               type:PostalAddress
            type:Organization
      name:Abbas Ghaderi
      url:http://orcid.org/0000-0003-0849-3375
      affiliation:
            name:Shiraz University of Medical Sciences
            address:
               name:Department of Immunology, School of Medicine, Shiraz University of Medical Sciences, Shiraz, Iran
               type:PostalAddress
            type:Organization
            name:Shiraz University of Medical Sciences
            address:
               name:Shiraz Institute for Cancer Research, School of Medicine, Shiraz University of Medical Sciences, Shiraz, Iran
               type:PostalAddress
            type:Organization
      email:[email protected]
PostalAddress:
      name:Department of Immunology, School of Medicine, Shiraz University of Medical Sciences, Shiraz, Iran
      name:Shiraz Institute for Cancer Research, School of Medicine, Shiraz University of Medical Sciences, Shiraz, Iran
      name:Shiraz Institute for Cancer Research, School of Medicine, Shiraz University of Medical Sciences, Shiraz, Iran
      name:Department of Pathology, School of Medicine, Shiraz University of Medical Sciences, Shiraz, Iran
      name:Department of Pathology, School of Medicine, Shiraz University of Medical Sciences, Shiraz, Iran
      name:Department of Pathology, School of Medicine, Shiraz University of Medical Sciences, Shiraz, Iran
      name:Department of Biostatistics, Shiraz University of Medical Sciences, Shiraz, Iran
      name:Breast Disease Research Center, School of Medicine, Shiraz University of Medical Sciences, Shiraz, Iran
      name:Breast Disease Research Center, School of Medicine, Shiraz University of Medical Sciences, Shiraz, Iran
      name:Department of Immunology, School of Medicine, Shiraz University of Medical Sciences, Shiraz, Iran
      name:Shiraz Institute for Cancer Research, School of Medicine, Shiraz University of Medical Sciences, Shiraz, Iran
WebPageElement:
      isAccessibleForFree:
      cssSelector:.main-content

External Links {🔗}(182)

Analytics and Tracking {📊}

  • Google Tag Manager

Libraries {📚}

  • Clipboard.js
  • Prism.js

4.65s.